Scientists track children for 7 years to unlock HIV cure clues
NCT ID NCT05154513
Summary
This study is observing children who started HIV medication within weeks of birth to understand their long-term health, immune system, and virus levels. About 250 children will be followed for up to seven years with regular check-ups and sample collection. The goal is to gather detailed information to help design future research aimed at achieving HIV remission or a cure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
30300, Umlazi Clinical Research Site
Durban, South Africa
-
31798, Baylor-Uganda Clinical Research Site
Kampala, Uganda
-
5030, Emory University School of Medicine Clinical Research Site
Atlanta, Georgia, 30322, United States
-
5055, South Florida CDTC Fort Lauderdale Clinical Research Site
Fort Lauderdale, Florida, 33316, United States
-
5071, Instituto de Puericultura e Pediatria Martagao Gesteira Clinical Research Site
Rio de Janeiro, Brazil
-
5121, Kenya Medical Research Institute/Walter Reed Project Clinical Research Center Kericho Clinical Research Site
Kericho, Kenya
-
5128, Texas Children's Hospital Clinical Research Site
Houston, Texas, 77030, United States
-
8051, Wits RHI Shandukani Research Centre Clinical Research Site
Johannesburg, South Africa
-
Chiang Rai Regional Hospital (5116)
Chiang Rai, Thailand
-
College of Med. JHU CRS (30301)
Blantyre, Malawi
-
David Geffen School of Medicine at UCLA (CRS 5112)
Los Angeles, California, 90095, United States
-
Family Clinical Research Unit (FAM-CRU) CRS (8950)
Tygerberg Hills, South Africa
-
Gaborone CRS 12701
Gaborone, Botswana
-
Harare Family Care (31890)
Harare, Zimbabwe
-
Hospital Geral De Nova Igaucu (5097)
Rio de Janeiro, Brazil
-
Hospital dos Servidores Rio de Janeiro
Rio de Janeiro, Brazil
-
Kilimanjaro Christian Medical Centre (5118)
Moshi, Tanzania
-
Les Centres GHESKIO (30022)
Port-au-Prince, Haiti
-
Molepolole Prevention/Treatment Trials CRS 12702
Molepolole, Botswana
-
Ribeirao Preto Medical School, University of Sao Paulo (5074)
São Paulo, Brazil
-
School of Medicine, University of Minas Gerais - FUNDEP (5073)
Belo Horizonte, Brazil
-
Seke North CRS 30306
Chitungwiza, Zimbabwe
-
Siriraj Hospital Mahidol University CRS (5115)
Bangkok, Ratchathewi, 10700, Thailand
-
Soweto IMPAACT CRS (8052)
Johannesburg, Gauteng, South Africa
-
St. Mary's CRS 30303
Chitungwiza, Zimbabwe
-
Univ of Miami Pediatric/Perinatal HIV/AIDS (5127)
Miami, Florida, 33136, United States
-
University of Colorado (5052)
Aurora, Colorado, 80045, United States
-
University of North Carolina Lilongwe (12001)
Lilongwe, Malawi
Conditions
Explore the condition pages connected to this study.